Atlas Trials

Clinical Evaluation of Lyral® Dose Response Study

Clinical trial NCT02028182 · COMPLETED

Trial details

NCT number
NCT02028182
Sponsor
Allerderm
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Contact Dermatitis
Start date
2013-02-01
Primary completion
2013-06-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.